FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

763037006: Acalabrutinib (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3637619010 Acalabrutinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3637620016 Acalabrutinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Acalabrutinib Is a Benzimidazole (substance) true Inferred relationship Some
Acalabrutinib Has disposition (attribute) Non-specific protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Acalabrutinib Is a Non-specific protein-tyrosine kinase inhibitor true Inferred relationship Some
Acalabrutinib Is a Enzyme inhibitor false Inferred relationship Some
Acalabrutinib Is a Antineoplastic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing acalabrutinib (medicinal product) Has active ingredient True Acalabrutinib Inferred relationship Some 1
Acalabrutinib-containing product in oral dose form Has active ingredient True Acalabrutinib Inferred relationship Some 1
Acalabrutinib only product Has active ingredient True Acalabrutinib Inferred relationship Some 1
Acalabrutinib only product in oral dose form Has active ingredient True Acalabrutinib Inferred relationship Some 1
Acalabrutinib 100 mg oral capsule Has precise active ingredient True Acalabrutinib Inferred relationship Some 1
Acalabrutinib 100 mg oral capsule Has basis of strength substance (attribute) True Acalabrutinib Inferred relationship Some 1
Product containing precisely acalabrutinib 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Acalabrutinib Inferred relationship Some 1
Product containing precisely acalabrutinib 100 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Acalabrutinib Inferred relationship Some 1

This concept is not in any reference sets

Back to Start